Hasil Pencarian - Martin S Naradikian

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    HLA-A∗02-gated safety switch for cancer therapy has exquisite specificity for its allelic target antigen

    HLA-A∗02-gated safety switch for cancer therapy has exquisite specificity for its allelic target antigen oleh Jee-Young Mock, Aaron Winters, Timothy P. Riley, Richele Bruno, Martin S. Naradikian, Shruti Sharma, Claudia A. Jette, Ryan Elshimali, Casey Gahrs, Dora Toledo-Warshaviak, Anthony P. West, Jr., Alexander Kamb, Agnes E. Hamburger

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Tumor cells fail to present MHC-II–restricted epitopes derived from oncogenes to CD4+ T cells

    Tumor cells fail to present MHC-II–restricted epitopes derived from oncogenes to CD4+ T cells oleh Spencer E. Brightman, Martin S. Naradikian, Rukman R. Thota, Angelica Becker, Leslie Montero, Milad Bahmanof, Ashmitaa Logandha Ramamoorthy Premlal, Jason A. Greenbaum, Bjoern Peters, Ezra E.W. Cohen, Aaron M. Miller, Stephen P. Schoenberger

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells

    Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells oleh Breanna DiAndreth, Kiran Deshmukh, Jee-Young Mock, Talar Tokatlian, Alexander Kamb, Shruti Sharma, Grace E Asuelime, Dora Toledo Warshaviak, Mark E Daris, Kristian Bolanos, Breanna L Luna, Martin S Naradikian, Agnes E Hamburger

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: